Notable Labs

Notable Labs is accelerating the process of determining which drugs or combinations are most likely to be effective for groups of blood cancer patients. While most drug companies look to address the largest possible group of patients, Notable looks first for groups with unmet needs and can accurately predict which drugs or drug combinations are likely to have a high success rate there. Notable will introduce its first drugs in 2019.